AIHP welcomes Catherine Taglieri, Pharm.D., and John Grabenstein, Ph.D., to its Board of Directors.
Professor Taglieri is a registered pharmacist and Associate Professor of Pharmacy Practice at MCPHS University (formerly known as the Massachusetts College of Pharmacy and Health Sciences). She has practiced in a variety of different pharmacy settings, including community, consulting and long-term care. She received both a B.S. in Pharmacy and a Pharm.D. from MCPHS University. For the past ten years she has served as one of the faculty coordinators for the Introductory and Advanced Practice courses and pharmacy skills labs for MCPHS University.
Taglieri’s area of research is primarily in the scholarship of teaching and learning, but she also has published abstracts and brief articles in the field of pharmaceutics and the history of pharmacy. She currently serves as the Editor for the AACP’s History of Pharmacy SIG (Special Interest Group) Newsletter and previously served as Secretary of the SIG.
John Grabenstein, Ph.D., is Global Director of Medical Affairs for Merck Vaccines. He leads medical-affairs and scientific-policy activities for Merck’s global vaccine enterprise that provides 150 million doses annually for 12 vaccines. A pharmacist, he has experience in over 50 countries, has served on multiple committees advising the U.S. Government, and has published nine books and more than 400 articles, primarily on topics of immunization, public health, and leadership.
Previously, as a Colonel in the United States Army, Dr. Grabenstein directed the Military Vaccine Agency where he oversaw the Defense Department immunization programs for 9 million troops, retirees, and family members spread across 4 continents and dozens of ships at sea.
Dr. Grabenstein received his pharmacy degree from Duquesne University in 1980, a master’s degree in education from Boston University in 1988, and his doctorate in epidemiology at the University of North Carolina in 1999.
Professor Taglieri has been appointed to serve a two-year term, and Dr. Grabenstein has been appointed to serve a one-year term. Both are expected to be nominated to run for full terms at the close of their current appointments.
